Oct 2026· European Journal of Pharmacology· Vol 1038, pp.
179468
· 0 citations· 28 references
Medicine
TL;DR
An important molecular circuit underlying stromal remodeling in OSCC is delineated, the disruption of which can potentially prevent the CAF-driven immune barrier formation and overcome therapeutic resistance in OSCC.
Abstract
The persistent progression and therapeutic resistance remain formidable challenges in the clinical management of malignancies. A pivotal mechanism underlying these clinical challenges is the formation of a tumor immune barrier at the tumor margin, which physically and functionally excludes immune cells from the tumor core. This barrier is primarily constructed by cancer-associated fibroblasts (CAFs), however, the precise mechanisms directing the reprogramming of resident normal fibroblasts (NFs) into these CAFs remain inadequately defined. In this study, we utilized spatial transcriptomics to confirm the presence of a CAF-rich immune barrier at the tumor margin of oral squamous cell carcinoma (OSCC). By performing integrated single-cell sequencing data analysis and functional assays, we identified osteopontin (SPP1) derived by OSCC cells as the predominant paracrine initiator of fibroblast reprogramming. Mechanistically, SPP1 binds the CD44 receptor on NFs to activate the PI3K/AKT/Twist signaling axis, which drives their transition into CAFs characterized by enhanced collagen production and increased invasive capacity. Notably, we demonstrated a self-reinforcing positive feedback loop wherein Twist activation upregulates CD44 expression, thereby amplifying fibroblast sensitivity to SPP1 and further sustaining the CAF phenotype. Pharmacological or genetic inhibition of any node within the SPP1/CD44/PI3K/Twist axis effectively attenuated the NF-to-CAF transformation and reduced collagen production. Our findings delineate an important molecular circuit underlying stromal remodeling in OSCC, the disruption of which can potentially prevent the CAF-driven immune barrier formation and overcome therapeutic resistance in OSCC.
This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.
C. Acevedo, Sayan Chakraborty, Samara P. Singh et al.· Cancer Research· 0 citations
This study delineates a novel CAF-driven immunosuppressive pathway in HCC, where CD147+ CAFs enhance tumor cell PD-L1 expression and susceptibility to immune checkpoint blockade via a TIMP2/MMP2/IL-6 axis.
Yi-Fei Wang, Bo-Wei Lv, Xiao-Jing Su et al.· Asia-Pacific Journal of Clin...· 0 citations
Fibroblast-intrinsic p38α MAPK is established as a central regulator of the early PSC-to-CAF transition, coupling inflammatory and tumor-derived signals to chromatin remodeling and sustained stromal activation.
Sayan Chakraborty, C. Acevedo, Samara P. Singh et al.· Cancer Research· 0 citations
It is suggested that the SHMT2–lactate–CAF axis contributes to the metabolic–stromal regulation of T-cell exclusion and may represent a potential therapeutic target for improving the response of immune-excluded HNSCC to PD-1 blockade.
He-Lei Yan, Lu Wang, Zhen Li et al.· Cell Death & Disease· 0 citations
Tumor associated macrophages (TAM) are key regulator of the tumor microenvironment (TME), however, the upstream factors that contribute to the polarization and functional reprogramming in oral squamous cell carcinoma (OSCC) remain largely unclear. This study evaluates the role of Nectin-4 in modulating tumor-immune int...